Jefferies analyst Jack Slevin lowered the firm’s price target on Cross Country Healthcare (CCRN) to $8.65 from $12.29 and keeps a Hold rating on the shares. The firm notes the company announced this morning that their proposed acquisition by Aya had been terminated. They will receive the $20M breakup fee from Aya, and it announced intent to immediately begin buying back shares under their existing $40M authorization, Jefferies adds.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCRN:
- Cross Country upgraded to Outperform from Market Perform at Citizens JMP
- Cross Country Healthcare: Navigating Post-Acquisition Challenges with Financial Stability and Growth Potential
- Cross Country Healthcare Ends Merger with Aya Holdings
- Cross Country Healthcare, Aya Healthcare merger agreement terminated
- Cross Country Healthcare Reports Q3 2025 Financial Results